Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Saved in:
| Title: | Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial. |
|---|---|
| Authors: | Keystone EC; Mt. Sinai Hospital, Toronto, Ontario, Canada. edkeystone@mtsinai.on.ca, Schiff MH, Kremer JM, Kafka S, Lovy M, DeVries T, Burge DJ |
| Source: | Arthritis and rheumatism [Arthritis Rheum] 2004 Feb; Vol. 50 (2), pp. 353-63. |
| Publication Type: | Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370605 Publication Model: Print Cited Medium: Print ISSN: 0004-3591 (Print) Linking ISSN: 00043591 NLM ISO Abbreviation: Arthritis Rheum Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
